Substantial morbidity for hospitalized children with community-Acquired rotavirus infections: 2005-2007 IMPACT surveillance in Canadian hospitals

Pediatric Infectious Disease Journal

Volumn 29, Issue 9, 2010, Pages 879-882

  Le Saux, Nicole ^a   Bettinger, Julie A ^b   Halperin, Scott A ^c   Vaudry, Wendy ^d   Scheifele, David W ^b  

^a CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c IWK HEALTH CENTRE   (Canada)

^d UNIVERSITY OF ALBERTA   (Canada)

Author keywords

children; hospitalizations; morbidity from rotavirus infections; pediatric hospital surveillance; rotavirus infections

Indexed keywords

ADOLESCENT; ARTICLE; CANADA; CHILD; CHILD HOSPITALIZATION; CLINICAL FEATURE; COMMUNITY; DEHYDRATION; DISEASE SEVERITY; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MORBIDITY; NONHUMAN; PRIORITY JOURNAL; ROTAVIRUS; SEIZURE; SEPSIS; VIRUS INFECTION;

EID: 77955981153     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3181e20c94     Document Type: Article

References (12)

1. Malek MA, Curns AT, Holman RC, et al. Diarrhea-and rotavirus-associ-ated hospitalizations among children less than 5 years of age: United States, 1997 and 2000. Pediatrics. 2006;117:1887-1892.
2. Charles MD, Holman RC, Curns AT, et al. Hospitalizations associated with rotavirus gastroenteritis in the United States, 1993-2002. Pediatr Infect Dis J. 2006;25:489-493.
3. Senecal M, Brisson M, Lebel MH, et al. Measuring the Impact of Rotavirus Acute Gastroenteritis Episodes (MIRAGE): a prospective community-based study. Can J Infect Dis Med Microbiol. 2008;19:397-404.
4. Vesikari T, Matson DO, Dennehy P, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med. 2006;354:23-33.
5. Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med. 2006;354:11-22.
6. Scheifele D. IMPACT after 17 years: lessons learned about successful networking. Paediatr Child Health. 2009;14:33-35.
7. Forster J, Guarino A, Parez N, et al. Hospital-based surveillance to estimate the burden of rotavirus gastroenteritis among European children younger than 5 years of age. Pediatrics. 2009;123:e393-e400.
8. Ford-Jones EL, Wang E, Petric M, et al; The Greater Toronto Area/Peel Region PRESI Study Group; Pediatric Rotavirus Epidemiology Study for Immunization. Hospitalization for community-acquired, rotavirus-associ-ated diarrhea: a prospective, longitudinal, population-based study during the seasonal outbreak. Arch Pediatr Adolesc Med. 2000;154:578-585.
9. Centers for Disease Control and Prevention. Delayed onset and diminished magnitude of rotavirus activity-United States, November 2007-May 2008. Morb Mortal Wkly Rep. 2008;57:697-700.
10. Wildi-Runge S, Allemann S, Schaad UB, et al. A 4-year study on clinical characteristics of children hospitalized with rotavirus gastroenteritis. Eur JPediatr. 2009;168:1343-1348.
11. Johansen K, Hedlund KO, Zweygberg-Wirgart B, et al. Complications attributable to rotavirus-induced diarrhoea in a Swedish paediatric population: report from an 11-year surveillance. Scand J Infect Dis. 2008;40:958-964.
12. Curns AT, Coffin F, Glasser JW, et al. Projected impact of the new rotavirus vaccination program on hospitalizations for gastroenteritis and rotavirus disease among US children